Clinical Trial Update: Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment [Phase 2]

View source ↗

Summary

A phase 2 investigator-initiated pilot trial assessing tumor response of squamous cell carcinoma lesions in patients treated with lapatinib; the single-center s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: University of Zurich | Conditions: Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED